1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Patient characteristicsa
Characteristics
 Clinical presentation
  Male sex (%)28 (47.5%)
  Age (median) (IQR) (yr)10.1 (7.2–13.0)
  Headaches50 (84.7%)
  Seizures15 (25.4%)
  Emesis37 (62.7%)
  Focal deficit22 (37.3%)
  GCS (median) (IQR)14 (3–15)
ICH characteristics
 Supratentorial location41 (69.5%)
 ICH volume (median) (IQR) (mL)10.9 (0.1–58)
 ICH/TBV (median) (IQR) (%)1.2 (0.8–5.6)
 IVH8 (13.6%)
Treatment characteristics
 Total No. of treatments105
 Patients treated with unimodal treatment38 (64.4%)
 Patients treated with multimodal treatment21 (35.6%)
 No. of treatment sessions (median) (IQR)1 (1–6)
 EVT58 (55.2%)
 EVT (No. of sessions) (median) (IQR)1.5 (1–5)
 SRS26 (24.8%)
 Partial surgery6 (5.7%)
 Complete surgery15 (14.3%)
AVM characteristics
 Brain AVM59 (100%)
  SM grade 1–238 (64.4%)
  SM grade 314 (23.7%)
  SM grade 4–57 (11.9%)
 Supratentorial49 (83%)
 Deep31 (52.5%)
 Eloquent area33 (55.9%)
 Nidus size (median) (IQR) (mm)22 (9–60)
 Compact nidus38 (64.4%)
 Aneurysm (arterial/venous)25 (42.4%)
 Any deep venous drainage30 (50.8%)
  • Note:—GCS, indicates Glasgow Coma Scale; ICH, intracerebral hemorrhage; TBV, total brain volume; IVH, intraventricular hemorrhage; SM, Spetzler-Martin.
  • ↵a Variables are displayed as No. (%) or median (25th to 75th quantiles).